Research and Markets (http://www.researchandmarkets.com/research/shfqkh/soft_tissue) has announced the addition of the "Soft Tissue Sarcoma-Pipeline Insights, 2014" subscription to their offering.
This Soft Tissue Sarcoma-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Soft Tissue Sarcoma.
This report provides information on the therapeutic development based on the Soft Tissue Sarcoma dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Soft Tissue Sarcoma Overview
- Soft Tissue Sarcoma Pipeline Therapeutics
- Soft Tissue Sarcoma Therapeutics under Development by Companies
- Soft Tissue Sarcoma Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Soft Tissue Sarcoma Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Soft Tissue Sarcoma Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Soft Tissue Sarcoma Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Soft Tissue Sarcoma - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Soft Tissue Sarcoma - Discontinued Products
- Soft Tissue Sarcoma - Dormant Products
- Companies Involved in Therapeutics Development for Soft Tissue Sarcoma
- Appendix
For more information visit http://www.researchandmarkets.com/research/shfqkh/soft_tissue
